OnKure Therapeutics, Inc. (OKUR)
2.37
-0.16
(-6.14%)
USD |
NASDAQ |
Nov 06, 10:13
OnKure Therapeutics Shareholders Equity (Quarterly) : 157.74M for Sept. 30, 2026
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2026 | 157.74M |
| June 30, 2026 | 172.11M |
| March 31, 2026 | 184.35M |
| December 31, 2025 | 56.18M |
| September 30, 2025 | 66.43M |
| June 30, 2025 | 78.17M |
| March 31, 2025 | 90.65M |
| December 31, 2024 | 103.83M |
| September 30, 2024 | 74.02M |
| June 30, 2024 | 76.87M |
| March 31, 2024 | 81.24M |
| December 31, 2023 | 27.98M |
| Date | Value |
|---|---|
| September 30, 2023 | 114.94M |
| June 30, 2023 | 132.53M |
| March 31, 2023 | 87.08M |
| December 31, 2022 | 99.97M |
| September 30, 2022 | 112.04M |
| June 30, 2022 | 124.16M |
| March 31, 2022 | 135.32M |
| December 31, 2021 | 147.21M |
| September 30, 2021 | 156.21M |
| June 30, 2021 | 167.55M |
| March 31, 2021 | -48.72M |
| December 31, 2020 | -42.12M |
Shareholders' Equity Definition
Represents the value of Shareholders' Equity as of the close of the report date, belonging to both Preferred and Common Equity Shareholders.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Heron Therapeutics, Inc. | 6.908M |
| Tonix Pharmaceuticals Holding Corp. | 222.28M |
| Karyopharm Therapeutics, Inc. | -330.17M |
| Minerva Neurosciences, Inc. | -213.30M |
| Corbus Pharmaceuticals Holdings, Inc. | 102.24M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 167.08M |
| Total Liabilities (Quarterly) | 9.34M |
| Debt to Equity Ratio | 0.005 |
| Current Ratio | 18.84 |
| Net Debt Paydown Yield | 0.01% |